Samy Tadros joined Tango from Celgene, acquired by Bristol Myers Squibb, where he served as executive director, business development and global alliances. Samy worked at Celgene for more than ten years, leading multiple cross-functional teams and successfully closing many impactful and important transactions for Celgene. Samy’s transactions have spanned the spectrum from early research agreements to late stage development and commercialization deals. Before joining Celgene, Samy worked at Charles River Labs and Schering-Plough.
Samy has a Bachelor of Science degree in biochemistry from Concordia University, a master’s degree from the Temple University School of Pharmacy and a Master of Business Administration from Fairleigh Dickinson University.